Archive forJanuary, 2006

Rheumatoid arthritis treatment - Gonna make you sweat

Gonna make you sweat
journalnews.com - ELMSFORD When it comes to hot yoga, Melanie Patrick speaks with the conviction of the converted. During the first two months, she lost 10 pounds and touched her toes for the first time in her life. And the

Star-Eyewitness News 4'Student of the Week'
Arizona Daily Star - Inside the classroom: Alexus loves doing well in school. She has received straight A's on her report card every quarter since kindergarten."It makes me feel happy when I get a good grade, because my Mom and Dad are proud of me,"she said. Favorite

Comments

Rheumatoid arthritis - Amgen fourth-quarter profit up 20 percent

Amgen fourth-quarter profit up 20 percent
KESQ News - SAN FRANCISCO Amgen, the world's largest biotechnology company by sales, announced today its fourth-quarter earnings rose 20 percent. That increase was driven by sales of its

Amgen to create more than 1,000 jobs in UK, Ireland
Forbes - LONDON (AFX) - Amgen Inc today announced plans to create more than 1,000 jobs in the UK and Ireland as the world's biggest biotechnology company moves to expand in Europe. The US giant will invest 1 bln usd in new process development, bulk

Comments

Rheumatoid arthritis - (AFX UK Focus) 2006-01-25 18:17 GMT: Bristol-Myers net triples as sales ease 1% - UPDATE 3 

(AFX UK Focus) 2006-01-25 18:17 GMT: Bristol-Myers net triples as sales ease 1% - UPDATE 3 
Interactive Investor - Jan 25 10:42 AM
BOSTON (AFX) — Bristol-Myers Squibb reported Wednesday that fourth-quarter earnings more than tripled, but sales slipped 1% as patents expire on a number of its top products, thereby opening the door to generic competition.Save to My Web

U.S. stocks end lower on weak housing data, rate woes 
MarketWatch via Yahoo! Finance - Jan 25 1:24 PM
NEW YORK — U.S. stocks closed slightly lower Wednesday as a rise in long-term interest rates and weaker-than-expected housing data outweighed a drop in crude-oil prices and some solid earnings reports.Save to My Web

Comments

· « Previous entries